glp-1 asa guidelines Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement Holding GLP-1 Agonists Prior to

However, GLP-1 medication does not replace the need for behavior change

The specific peptides that have taken the fitness world by storm, however, tend to be involved in the production of growth hormone

body composition favors CJC-1295 Sensitivity to hormonal changes: Cautious patients often start with sermorelin Baseline lab work: IGF-1 levels, metabolic panel, and hormone assessments inform selection Lifestyle factors: Training intensity, diet quality, and sleep habits affect outcomes Budget and convenience: Dosing frequency and cost may influence the decision Provider experience: A knowledgeable provider can guide selection based on clinical response At Rewind Anti-Aging of Miami, peptide therapy is never one-size-fits-all

PMID: 73 CurradoDSaracinoFDe VincenzoFTrunfioFMarinoAKunLet al